EPTEST Trademark
Trademark Overview
On Tuesday, March 25, 2003, a trademark application was filed for EPTEST with the United States Patent and Trademark Office. The USPTO has given the EPTEST trademark a serial number of 78229836. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 17, 2004. This trademark is owned by Mindset Biopharmaceuticals (USA) Inc.. The EPTEST trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI); Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclona...
Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.; Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.
Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.; Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.
General Information
| Serial Number | 78229836 |
| Word Mark | EPTEST |
| Filing Date | Tuesday, March 25, 2003 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, March 17, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI); Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI) |
| Goods and Services | Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.; Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome. |
| Goods and Services | Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.; Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis. |
| Pseudo Mark | EPT TEST |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 3, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 3, 2003 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 3, 2003 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Mindset Biopharmaceuticals (USA) Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10018 |
Trademark Events
| Event Date | Event Description |
| Wednesday, March 17, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, August 27, 2003 | NON-FINAL ACTION MAILED |
| Thursday, August 21, 2003 | ASSIGNED TO EXAMINER |
| Monday, July 21, 2003 | CASE FILE IN TICRS |
| Monday, June 30, 2003 | PAPER RECEIVED |
